What is the promise of nicotinergic compounds in schizophrenia treatment?
Future Med Chem
.
2016 Nov;8(17):2009-2012.
doi: 10.4155/fmc-2016-0154.
Epub 2016 Oct 14.
Authors
Juliane K Mueller
1
,
Cathrin Rohleder
1
,
F Markus Leweke
1
Affiliation
1
Department of Psychiatry & Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, 68159 Mannheim, Germany.
PMID:
27739330
DOI:
10.4155/fmc-2016-0154
No abstract available
Keywords:
clinical trials; cognition; nicotinic acetylcholine receptor.